Future Rheumatology logo Future Medicine logo

Future Rheumatology provides analysis and commentary on our understanding of disease mechanisms, emerging therapeutic strategies and new diagnostic approaches. Key advances in the field are reported and analyzed by international experts, providing an authoritative but accessible forum for this expanding area of specialization.

Publisher: Future Medicine

Volume 1, Number 2, April 2006
Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

next issue > | all issues

Editorial

PTPN22: a confirmed rheumatoid arthritis susceptibility gene?
pp. 153-158(6)
Author: Hinks, Anne

Extracorporeal shock waves and bone: can we shock the cells into growth?
pp. 159-162(4)
Authors: Hausdorf, J; Maier, M

Bulletin Board

Efficacy of glucosamine and chondroitin sulfate linked to degree of pain
pp. 163-165(3)

Drug Evaluation

Role of abetimus in systemic lupus erythematosus
pp. 167-171(5)
Authors: Joshi, Manuja; Madaio, Michael P

Study Report

Gene therapy with the interleukin-1 receptor antagonist for the treatment of arthritis
pp. 173-178(6)
Authors: Evans, Christopher H; Ghivizzani, Steven C; Wehling, Peter; Robbins, Paul D

Review

Hematopoietic and mesenchymal stem cell transplantation in autoimmune diseases
pp. 179-188(10)
Authors: Tyndall, Alan; Dazzi, Francesco

How does HLA-B27 affect susceptibility to spondyloarthropathy?
pp. 189-197(9)
Authors: Goodall, Jane C; Gaston, JSH

Assessment of structure-modifying drugs in osteoarthritis: surrogate or hard clinical end points?
pp. 199-206(8)
Authors: Bruyere, Olivier; Reginster, Jean-Yves

Meniscectomy and osteoarthritis: what is the cause and what is the effect?
pp. 207-215(9)
Authors: Englund, Martin; Lohmander, L Stefan

Novel hints on the pathogenesis of lupus from in vivo models
pp. 217-224(8)
Authors: Rovere-Querini, Patrizia; Sabbadini, Maria Grazia; Di Comite, Gabriele; Manfredi, Angelo A

Antimalarials in systemic lupus erythematosus: benefits beyond disease activity
pp. 225-233(9)
Authors: Andrade, Rosa M; Alarcón, Graciela S

New therapies for systemic lupus erythematosus: has the future arrived?
pp. 235-247(13)
Authors: Kaul, Arvind; D'Cruz, David; Hughes, Graham RV

Citrulline and anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis
pp. 249-258(10)
Authors: Yamada, Ryo; Suzuki, Akari; Yamamoto, Kazuhiko

Potential role of statins and PPARs in rheumatoid arthritis
pp. 259-274(16)
Authors: Douglas, Karen MJ; Sattar, Naveed; Kitas, George D

next issue > | all issues

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A